Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 501 - 550 out of 13,391

Document Document Title
WO/2015/128344A1
Sialic acid derivatives of the formula (I) in which the symbols have the meanings given in the description, are suitable as medicaments, in particular for diseases the progression of which is influenced by Siclec ligands.  
WO/2015/126876A1
A comprehensive process for the separation, isolation and characterization of a combination of two or more steviol glycosides from extract of Stevia rebaudiana plants and their use in sweetening compositions are disclosed. Combinations o...  
WO/2015/125781A1
 A method for producing a compound represented by general formula (II) via a step for reacting a compound represented by general formula (I) with a sulfur compound, and a compound. In general formulas (I) and (II), R1 represents a hydr...  
WO/2015/121168A1
The invention relates to a yeast strain and to a method for microbial production of pentacyclic triterpenes and/or triterpenoids in yeast. More particularly, the invention relates to a modified yeast strain for production of pentacyclic ...  
WO/2015/006764A8
Rebaudioside M compositions with improved aqueous solubility and methods for preparing the same are provided herein. The rebaudioside M compositions include (i) disordered crystalline compositions comprising rebaudioside M and rebaudiosi...  
WO/2015/113370A1
Disclosed is a stevioside A glycoside crystal form 7, the structure whereof is represented by the formula I. The X-ray powder diffraction (XRPD) figure of the crystal form 7 has the following characteristic peaks at the angles of 2θ±0....  
WO/2015/113369A1
Disclosed is a stevioside A glycoside crystal form 9, of which the structure is represented by the formula I. The X-ray powder derivative (XRPD) figure of the crystal form 9 has the following characteristic peaks at the angles of 2θ±0....  
WO/2015/101916A1
An improved process for the preparation of empagliflozin is disclosed. Novel intermediates of formulas (13) and (14) for the preparation of empagliflozin are also disclosed, wherein R1 and R2 are independently hydrogen or hydroxyl protec...  
WO/2015/102018A1
This invention relates to Chlorophytum borivilianum, popularly known as Safed Musli. Currently, the active nutrition enhancing ingredients such as Stigmasterol and Hecogenin are extracted from the tuber of the product which is available ...  
WO/2015/019193A3
The present specification is directed to an acylated flavonoid derivative derived from natural or synthetic flavonoids such as phloridzin and isoquercitrin, and long chain fatty acids, mon- or poly- unsaturated once in particular. The ac...  
WO/2015/084846A1
The invention relates to an oligonucleotide including one or more modified nucleoside bases having the structure — B— L— A wherein for each of the modified nucleosides A is independently a monosaccharide or oligosaccharide, L is a ...  
WO/2015/081778A1
The present invention belongs to the field of organic synthesis, relates to a method for synthesizing a saponin, and in particular, to a method for constructing a glycosidic bond in a saponin, and comprises the following steps: directly ...  
WO/2015/085173A1
The invention comprises compounds, methods of making, and methods of using. The compounds may have a linear or cylic backbone and three or four appended functional groups: one or two lipohilic compounds including sterols or "fat soluble"...  
WO/2015/083561A1
The purpose of the present invention is to provide a disaccharide compound which can be optimally used to obtain a modified organopolysiloxane compound having excellent surface-active action. A further purpose is to provide a modified or...  
WO/2015/081438A1
It is provided a multivalent gangloside carbohydrate as a therapeutic cancer vaccine. The GD2 and GD3 carbohydrate conjugated disclosed are linked by a spacer to form a multimer which conserves the native structural feature of naturally ...  
WO/2015/067926A1
Chromogenic substrates for β-D-glucuronidase activity comprising monoglucuronides of some 1,2-dihydroxyaromatic derivatives. When cleaved these form soluble coloured conjugates with multivalent metal ions such as iron ions. The substrat...  
WO/2015/067927A1
Conjugates of 2,3-dihydroxynaphthalene and its derivatives with enzyme cleavable groups are chromogenic substrates that form coloured compounds when complexed with metal ions, e.g. iron ions, on cleavage by enzymes, and are useful in mic...  
WO/2015/051454A1
The present invention relates to nucleotide sequences encoding ent-kaurenoic acid 13- hydroxylase polypeptides and polypeptides having ent-kaurenoic acid 13-hydroxylase activity. The invention also relates to methods of producing steviol...  
WO/2014/115174A8
A process for synthesis of enatiomerically pure or enatiomerically enriched or racemic mixture of (+and/or-) epicatechin and its intermediates, comprising the steps of: (i) obtaining penta-protected quercetin; (ii) reducing the penta-pro...  
WO/2015/050240A1
The present invention provides a novel organic acid glycoside that is present in coffee beans and a use thereof. Provided is a compound having a structure represented by formula (1) [in the formula, R1-R7 are each selected independently ...  
WO/2015/043511A1
Disclosed are glucopyranosyl derivatives used as sodium dependent glucose cotransporters (SGLTs) inhibitors, intermediates or preparation processes thereof, and pharmaceutical uses thereof, especially glucopyranosyl derivatives represent...  
WO/2015/046183A1
The purpose of the present invention is to provide a glycoamino acid which is an amino acid precursor having improved properties (particularly solubility in water, stability in water, bitterness, etc.). The present invention relates to a...  
WO/2015/048616A1
Methods for treating and/or preventing mucositis comprising administering to a subject in need thereof an effective amount of at least one compound chosen from E-selectin antagonists, pharmaceutically acceptable salts of E-selectin antag...  
WO/2015/028548A1
Disclosed is tri- or tetravalent sialic acid derivatives comprising a core moiety to which 3 or 4 sialic acid residues are connected via a linker. Such derivatives inhibit the binding of adenovirus to human cells, whereby infections, suc...  
WO/2014/165107A3
The present invention relates to compounds useful for the treatment or prevention of bacteria infections. These compounds have formula (I) The invention also provides processes for making the compounds described herein. Furthermore, the ...  
WO/2015/023928A1
Sweetener compositions including at least 3% Rebaudioside N by weight based on the total weight of sweetener compounds in the sweetener composition are disclosed. The sweetener compositions are used to prepare sweetened compositions incl...  
WO/2015/020114A1
Provided is a novel sophorolipid (SL) that can be applied in a wide range of fields such as beverages, cosmetics, drugs, and quasi-drugs. This sophrolipid compound is represented by formula (I) (in formula (I), R1 represents H or a methy...  
WO/2015/019193A2
The present specification is directed to an acylated flavonoid derivative derived from natural or synthetic flavonoids and fatty acids. The acylated flavonoid derivatives can be part of a pharmaceutical composition. Method of decreasing ...  
WO/2015/020051A1
[Problem] The purpose of the present invention is to provide a method for extracting ceramide and/or pectin, which are useful components, from whole apples and/or apple juice residue. Another purpose of the present invention relating to ...  
WO/2015/014959A1
The present invention relates a process for the recovery of one or more steviol glycosides from a steviol glycoside-containing fermentation broth, which method comprises (a) providing a fermentation broth comprising one or more steviol g...  
WO/2015/011517A1
The present invention provides novel processes for the preparation of Fondaparinux sodium by using the compound of formula ABC5. In some embodiments, the intermediates for the synthesis of Fondaparinux sodium, are also provided.  
WO/2015/012110A1
 The purpose of the present invention is to provide a technique for manufacturing a C-glycoside derivative with high efficiency and in commercially advantageous conditions. A C-glycoside derivatives can be manufactured in a short perio...  
WO/2015/011441A1
The invention provides methods and materials for use in the detection of influenza viruses which utilise a nanoparticle, for example gold nanoparticule, probe comprising a plurality of glycoconjugate ligands, each glyconjugate ligand (GL...  
WO/2015/008007A1
The invention relates to novel solanidine-derived compounds, the synthesis method thereof and the uses of same in the fields of phytosanitary protection and health. In particular, the invention relates to novel compounds having toxic and...  
WO/2015/006763A1
Sweetened compositions comprising at least one sweetener and rebaudioside X are provided herein. Rebaudioside X is present in the sweetened compositions in a concentration at or below the sweetness recognition threshold, while the at lea...  
WO/2015/004041A1
The present invention relates to the total synthesis of saccharide structures contained in the capsular polysaccharide of Streptococcus pneumoniae type 1, to glycoconjugates containing said saccharide structures obtained by total synthes...  
WO/2012/132022A9
Provided is a compound represented by the formula (I): wherein R1 represents R5=N- (R5 represents a saccharide residue) or (R4 represents a mono- or polyethylene glycol residue); each of R2 and R3, whether identical or not, represents a ...  
WO/2015/006764A1
Rebaudioside M compositions with improved aqueous solubility and methods for preparing the same are provided herein. The rebaudioside M compositions include (i) disordered crystalline compositions comprising rebaudioside M and rebaudiosi...  
WO/2015/000132A1
The present invention provides a method for preparing epirubicin and an intermediate thereof related to the method. The preparation method may comprise: reacting tert-Butyldimethylsilyl chloride with N-trifluoroacetyl adriamycin to obtai...  
WO/2015/000792A1
The current invention is directed towards mixtures of compounds, comprising (A) in the range of from 93 to 97 % by weight compound of general formula (I) (B) in the range of from 3 to 6.5 % by weight compound of general formula (II) (C) ...  
WO/2014/206299A1
Disclosed in the present invention is a method for preparing a liflozin drug intermediate using a microreactor, comprising: mixing compound III dissolved in an organic solvent with an organometallic reagent in a microreactor unit (L) by ...  
WO/2014/146135A3
The present invention relates generally to steviol glycosides, as well as compositions comprising such steviol glycosides. The present invention further extends to methods of preparing and purifying such steviol glycosides and methods fo...  
WO/2014/203887A1
In the present invention, by applying a solution containing the fullerene represented by formula (1) to a substrate and firing at 450°C or higher, an n-type organic semiconductor thin film that has favorable ionization potential and has...  
WO/2014/204866A1
The present disclosure provides mixtures of prenylated flavonoids, stilbenes, or both with flavans or curcuminoids or both capable of modulating joint inflammation, joint pain, joint stiffness, cartilage degradation, or improving mobilit...  
WO/2014/115174A3
A process for synthesis of enatiomerically pure or enatiomerically enriched or racemic mixture of (+and/or-) epicatechin and its intermediates, comprising the steps of: (i) obtaining penta-protected quercetin; (ii) reducing the penta-pro...  
WO/2014/107652A3
The present invention provides vaccines comprising carbohydrate antigen conjugated to a diphtheria toxin (DT) as a carrier protein, wherein the ratio of the number of carbohydrate antigen molecule to the carrier protein molecule is highe...  
WO/2014/200363A1
The invention relates to sphingoglycolipid analogues which are useful in treating or preventing diseases and conditions such as those relating to infection, atopic disorders, autoimmune diseases or cancer.  
WO/2014/200964A1
The invention relates to processes for preparing (S,S)-secoisolariciresinol diglucoside and (R,R)-secoisolariciresinol diglucoside and compositions comprising the same.  
WO/2014/173957A3
A compound of formula (I) wherein R is a C9-23 polyunsaturated alkenyl group; X is SO3R3, SO2R3, PO3R3, PO2R3, COCHal3, or COOR3; R1 and R2 are each independently H, a C1-6 a iky I group optionally substituted with OH, C6-10 aryl group o...  
WO/2014/196887A1
Derived for the first time are individual (without the addition of penta- and hexa-acyl derivatives) di-, tri- and tetra-acyl S-LPS of endotoxic bacteria and combinations thereof, and the immunobiological, physicochemical and chemical...  

Matches 501 - 550 out of 13,391